US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 129.900
  • +3.240+2.56%
Close Oct 18 16:00 ET
  • 129.900
  • 0.0000.00%
Post 20:01 ET
7.76BMarket Cap-13866P/E (TTM)

Ascendis Pharma A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ascendis Pharma A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 86.580M--
--2024/Q3-- / 69.848M--
Sep 3, 20242024/Q235.998M / 84.468M--
May 2, 20242024/Q195.894M / 79.867M--
Feb 7, 20242023/Q4137.703M / 85.606M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 86.580M--
--2024/Q3-- / 69.848M--
Sep 3, 20242024/Q235.998M / 84.468M--
May 2, 20242024/Q195.894M / 79.867M--
Feb 7, 20242023/Q4137.703M / 85.606M--

Unlock Free Earnings Estimates

Ascendis Pharma A/S Earnings Reports

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 23 16:04 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 3 17:16 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 3 17:12 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    May 2 16:36 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Strong Buy

    • Buy

      92.86%

    • Hold

      7.14%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data